Page last updated: 2024-08-25

magnoflorine and Cancer of Stomach

magnoflorine has been researched along with Cancer of Stomach in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Adamczuk, G; Dmoszynska-Graniczka, M; Gawel, K; Grabarska, A; Juszczak, M; Kosheva, N; Kukula-Koch, W; Luszczki, JJ; Rzeski, W; Slawinska-Brych, A; Stepulak, A1
Ma, SY; Sun, XL; Zhai, HJ; Zhang, D; Zhang, XW1

Other Studies

2 other study(ies) available for magnoflorine and Cancer of Stomach

ArticleYear
Heterogeneous Cellular Response of Primary and Metastatic Human Gastric Adenocarcinoma Cell Lines to Magnoflorine and Its Additive Interaction with Docetaxel.
    International journal of molecular sciences, 2023, Oct-24, Volume: 24, Issue:21

    Topics: Adenocarcinoma; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Docetaxel; Humans; Stomach Neoplasms; Zebrafish

2023
Magnoflorine inhibits human gastric cancer progression by inducing autophagy, apoptosis and cell cycle arrest by JNK activation regulated by ROS.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 125

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Aporphines; Autophagy; Caspases; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Male; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Plant Extracts; Reactive Oxygen Species; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases

2020